124 related articles for article (PubMed ID: 15711113)
21. Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma.
Papworth K; Sandlund J; Grankvist K; Ljungberg B; Rasmuson T
Anticancer Res; 2010 Jul; 30(7):2953-7. PubMed ID: 20683038
[TBL] [Abstract][Full Text] [Related]
22. Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas.
Yoo H; Baia GS; Smith JS; McDermott MW; Bollen AW; Vandenberg SR; Lamborn KR; Lal A
Clin Cancer Res; 2007 Jan; 13(1):68-75. PubMed ID: 17200340
[TBL] [Abstract][Full Text] [Related]
23. The expressions of carbonic anhydrase 9 and vascular endothelial growth factor in astrocytic tumors predict a poor prognosis.
Yoo H; Sohn S; Nam BH; Min HS; Jung E; Shin SH; Gwak HS; Lee SH
Int J Mol Med; 2010 Jul; 26(1):3-9. PubMed ID: 20514415
[TBL] [Abstract][Full Text] [Related]
24. Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline.
Aomatsu N; Yashiro M; Kashiwagi S; Kawajiri H; Takashima T; Ohsawa M; Wakasa K; Hirakawa K
BMC Cancer; 2014 Jun; 14():400. PubMed ID: 24893880
[TBL] [Abstract][Full Text] [Related]
25. The use of MN/CA9 gene expression in identifying malignant solid renal tumors.
Li G; Cuilleron M; Cottier M; Gentil-Perret A; Lambert C; Genin C; Tostain J
Eur Urol; 2006 Feb; 49(2):401-5. PubMed ID: 16387417
[TBL] [Abstract][Full Text] [Related]
26. Carbonic anhydrase IX expression is associated with favorable prognostic factors in small intestinal carcinoma.
Gu MJ; Kwon KW
J Histochem Cytochem; 2014 Mar; 62(3):205-10. PubMed ID: 24217923
[TBL] [Abstract][Full Text] [Related]
27. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED
J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723
[TBL] [Abstract][Full Text] [Related]
28. Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.
Atkins M; Regan M; McDermott D; Mier J; Stanbridge E; Youmans A; Febbo P; Upton M; Lechpammer M; Signoretti S
Clin Cancer Res; 2005 May; 11(10):3714-21. PubMed ID: 15897568
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation.
Duivenvoorden WC; Hopmans SN; Gallino D; Farrell T; Gerdes C; Glennie D; Lukka H; Pinthus JH
Oncol Rep; 2015 Oct; 34(4):1968-76. PubMed ID: 26252502
[TBL] [Abstract][Full Text] [Related]
30. Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival.
Kim JY; Lee SH; An S; Kim SJ; Sung YN; Song KB; Hwang DW; Kim SC; Hong SM
Virchows Arch; 2018 May; 472(5):739-748. PubMed ID: 29666945
[TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies.
Al-Ahmadie HA; Alden D; Qin LX; Olgac S; Fine SW; Gopalan A; Russo P; Motzer RJ; Reuter VE; Tickoo SK
Am J Surg Pathol; 2008 Mar; 32(3):377-82. PubMed ID: 18300814
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
33. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.
Uemura H; Nakagawa Y; Yoshida K; Saga S; Yoshikawa K; Hirao Y; Oosterwijk E
Br J Cancer; 1999 Oct; 81(4):741-6. PubMed ID: 10574265
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
Tickoo SK; Alden D; Olgac S; Fine SW; Russo P; Kondagunta GV; Motzer RJ; Reuter VE
J Urol; 2007 Apr; 177(4):1258-63. PubMed ID: 17382701
[TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes.
Baniak N; Flood TA; Buchanan M; Dal Cin P; Hirsch MS
Histopathology; 2020 Oct; 77(4):659-666. PubMed ID: 32639054
[TBL] [Abstract][Full Text] [Related]
36. [The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma].
Nakagawa Y; Uemura H; Shimizu K; Cho M; Yoshikawa M; Hirao Y; Yoshikawa K
Hinyokika Kiyo; 2001 Nov; 47(11):809-14. PubMed ID: 11771176
[TBL] [Abstract][Full Text] [Related]
37. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma.
Kuroda N; Agatsuma Y; Tamura M; Martinek P; Hes O; Michal M
Int J Clin Exp Pathol; 2015; 8(2):2131-8. PubMed ID: 25973115
[TBL] [Abstract][Full Text] [Related]
38. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
[TBL] [Abstract][Full Text] [Related]
39. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]